Free Trial

Virtus LifeSci Biotech Clinical Trials ETF Rating

$42.53 -0.61 (-1.41%)
Closing price 11/13/2026 04:10 PM Eastern
Extended Trading
$42.50 -0.02 (-0.06%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2026)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

BBC Aggregate Rating

Moderate Buy
2.78

Holdings in BBC have an aggregate rating of Moderate Buy based on 301 analyst ratings issued in the past year covering 25 companies (33.5% of the portfolio).

BBC Aggregate Price Target

$42.53
High Prediction$42.53
Average Prediction$42.53
Low Prediction$42.53

Holdings in BBC have an aggregate price target of $42.53 and a range of $42.53 to $42.53 covering 25 companies (33.5% of the portfolio).

BBC Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
Moderate Buy
21 Moderate Buy rating(s)
Hold
0 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 25 BBC Holdings

Weight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)View
Ratings
2.25%
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$111.19
+2.7%
Moderate Buy$109.00 -2.0%8
1.8707 of 5 stars
2.24%
Xencor, Inc. stock logo
XNCR
Xencor
$37.09
-2.7%
Moderate Buy$42.22 13.8%11
2.1078 of 5 stars
2.10%
TRAX
First Tracks Biotherapeutics
$47.10
-3.3%
Moderate Buy$72.17 53.2%14
3.639 of 5 stars
1.88%
Replimune Group, Inc. stock logo
REPL
Replimune Group
$21.89
-0.4%
Moderate Buy$14.33 -34.5%10
1.4905 of 5 stars
1.75%
AbCellera Biologics Inc. stock logo
ABCL
AbCellera Biologics
$11.49
-1.1%
Moderate Buy$16.20 41.0%11
3.9546 of 5 stars
1.56%
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$30.29
+1.4%
Buy$43.71 44.3%9
3.1164 of 5 stars
1.55%
Spyglass Pharma, Inc. stock logo
SGP
Spyglass Pharma
$32.88
-1.3%
Moderate Buy$45.83 39.4%9
3.3228 of 5 stars
1.35%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$30.87
+1.3%
Moderate Buy$41.00 32.8%12
3.7355 of 5 stars
1.30%
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
$4.27
+9.8%
Moderate Buy$7.86 84.0%9
3.5317 of 5 stars
1.25%
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
$152.48
-0.5%
Buy$213.85 40.2%15
2.6811 of 5 stars
1.18%
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
$127.57
+0.3%
Moderate Buy$139.16 9.1%27
2.0016 of 5 stars
1.14%
LB Pharmaceuticals Inc stock logo
LBRX
LB Pharmaceuticals
$43.01
+1.3%
Moderate Buy$57.40 33.5%13
2.3912 of 5 stars
1.14%
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$105.35
+0.3%
Moderate Buy$141.80 34.6%10
2.8221 of 5 stars
1.12%
Veradermics, Incorporated stock logo
MANE
Veradermics
$129.18
-4.5%
Moderate Buy$174.57 35.1%9
3.1 of 5 stars
1.12%
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
$55.94
+2.6%
Moderate Buy$87.30 56.1%14
2.9834 of 5 stars
1.10%
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$9.96
-17.8%
Moderate Buy$22.57 126.6%9
2.4245 of 5 stars
1.10%
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$28.01
+1.3%
Moderate Buy$46.71 66.8%9
3.2805 of 5 stars
1.10%
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
$34.33
-4.9%
Buy$65.50 90.8%13
2.7052 of 5 stars
1.07%
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$12.23
+1.0%
Moderate Buy$30.22 147.1%11
2.9502 of 5 stars
1.07%
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
$19.42
+0.5%
Buy$38.29 97.1%9
2.0448 of 5 stars
1.05%
Septerna, Inc. stock logo
SEPN
Septerna
$42.60
+1.8%
Moderate Buy$56.44 32.5%11
2.2849 of 5 stars
1.04%
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$63.37
-2.0%
Moderate Buy$110.50 74.4%9
3.1346 of 5 stars
1.04%
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
$32.08
-2.8%
Moderate Buy$66.24 106.5%21
3.1822 of 5 stars
1.00%
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
$45.93
+0.2%
Moderate Buy$52.83 15.0%12
2.413 of 5 stars
1.00%
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
$11.37
-1.0%
Moderate Buy$36.92 224.7%16
2.8634 of 5 stars

This page (NYSEARCA:BBC) was last updated on 11/15/2026 by MarketBeat.com Staff.
From Our Partners